Cynthia Collins serves as a Board Member for several organizations, including MaxCyte, Inc., the Foundation for mRNA Medicines, Alanis Therapeutics Inc., and Nutcracker Therapeutics. Additionally, Cynthia holds the position of Lead Director at Panavance Therapeutics Inc.
Links
Sign up to view 0 direct reports
Get started
This person is not in any teams